Ophthalmology

Retina specialist Caroline Baumal, MD, has been appointed the chief medical officer of Apellis Pharmaceuticals. 

St. Louis-based EyeCare Partners has partnered with Retinal Associates of Oklahoma to create more specialty retina care practices within Oklahoma. 

EyePoint Pharmaceuticals has tapped its COO, Jay Duker, MD, as its next president. 

Boca Raton, Fla.-based Premier Eye Care has been acquired by Health Network One, a health management company backed by private equity investment firm H.I.G. Capital. 

Display technology provider BenQ has collaborated with blue light mitigating technology provider Eyesafe to develop a new computer monitor that reduces blue light toxicity on display systems. 

Iveric Bio, a biopharmaceutical company for retinal diseases, has named Pravin Dugel, MD, to its board of directors. 

Cataract surgery cost an average of $3,500 to $7,000 per eye in 2022, according to data from eye research company MyVision.org.  

Retina Consultants of America has added its 30th partnership with the announcement of Retina Group of New England joining its national network of physicians in a Dec. 30 release. 

A physician at N.C.-based Wilmington Eye performed the first successful implant of the iStent Infinite at Wilmington Eye Surgery Center. This marks the first time a glaucoma device has been implanted in either of the Carolinas.

The Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine has been named the top ophthalmology residency program in the U.S. for 2022 by Ophthalmology Times.